Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Angiopoietin-1 is essential in mouse vasculature during development and in response to injury
Marie Jeansson, Alexander Gawlik, Gregory Anderson, Chengjin Li, Dontscho Kerjaschki, Mark Henkelman, Susan E. Quaggin
Marie Jeansson, Alexander Gawlik, Gregory Anderson, Chengjin Li, Dontscho Kerjaschki, Mark Henkelman, Susan E. Quaggin
View: Text | PDF
Research Article

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury

  • Text
  • PDF
Abstract

Angiopoietin-1/Tek signaling is a critical regulator of blood vessel development, with conventional knockout of angiopoietin-1 or Tek in mice being embryonically lethal due to vascular defects. In addition, angiopoietin-1 is thought to be required for the stability of mature vessels. Using a Cre-Lox conditional gene targeting approach, we have studied the role of angiopoietin-1 in embryonic and adult vasculature. We report here that angiopoietin-1 is critical for regulating both the number and diameter of developing vessels but is not required for pericyte recruitment. Cardiac-specific knockout of angiopoietin-1 reproduced the phenotype of the conventional knockout, demonstrating that the early vascular abnormalities arise from flow-dependent defects. Strikingly, deletion in the entire embryo after day E13.5 produced no immediate vascular phenotype. However, when combined with injury or microvascular stress, angiopoietin-1 deficiency resulted in profound organ damage, accelerated angiogenesis, and fibrosis. These findings redefine our understanding of the biological roles of angiopoietin-1: it is dispensable in quiescent vessels but has a powerful ability to modulate the vascular response after injury.

Authors

Marie Jeansson, Alexander Gawlik, Gregory Anderson, Chengjin Li, Dontscho Kerjaschki, Mark Henkelman, Susan E. Quaggin

×

Figure 4

Angpt1 regulates both the number and diameter of developing vessels.

Options: View larger image (or click on image) Download as PowerPoint
Angpt1 regulates both the number and diameter of developing vessels.
(A)...
(A) Breeding strategy to generate inducible whole-body deletion of Angpt1 [Angpt1del/^(DOX) mice] using the DOX-inducible ROSA-rtTA/tetO-Cre bitransgenic system. (B) Induction of Angpt1 knockout at E10.5 [Angpt1del/^(E10.5) mice] or earlier results in embryonic lethality. In mice induced with DOX at E10.5, vessels are dilated at P0 (C and D) in the heart (original magnification, ×50), (E and F) liver (original magnification, ×50), and (G and H) kidney (original magnification, ×50). Pericytes/mural cells surround the vessels as shown by α-SMA staining of (I–L) liver and (M and N) lung in embryos dissected at E17.5 (See also Supplemental Figure 3). Scale bar: 10 μm (I and J); 100 μm (K and L); 50 μm (M and N). (V and X) In the same embryos, measurements of vessel number and vessel area in the liver showed a significant increase of both in Angpt1del/^(E10.5) embryos compared with those in controls. Deletion of Angpt1 at E10.5 also resulted in dilated glomerular capillary loops by E17.5, as shown by (O and P) H&E and (Q and R) podocin staining (scale bar: 10 μm), and a few glomeruli with only 1 big open capillary loop by P0, as shown by (S and T) Toluidine Blue staining (scale bar: 10 μm). (U) Electron micrographs (scale bar: 5 μm) show a folded GBM (arrow) and detachment of endothelial cells (*).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts